共 6 条
- [3] Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)[J] . O. Katopodis,J. Souglakos,E. Stathopoulos,A. Christopoulou,E. Kontopodis,A. Kotsakis,K. Kalbakis,N. Kentepozidis,A. Polyzos,D. Hatzidaki,V. Georgoulias. Cancer Chemotherapy and Pharmacology . 2014 (2)
- [4] Cancer statistics, 2014[J] . Rebecca Siegel,Jiemin Ma,Zhaohui Zou,Ahmedin Jemal. CA A Cancer Journal for Clinicians . 2014 (1)